NSIM
RMD icon

North Star Investment Management’s ResMed RMD Stock Holding History

North Star Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13
Closed -$2.92K – 1824
2026
Q1 		$2.92K Buy
13
+4
+44% +$997 ﹤0.01% 1342
2025
Q4 		$2.17K Buy
+9
New +$2.3K ﹤0.01% 1318
2023
Q4 		– Sell
-5
Closed -$739 – 1273
2023
Q3 		$739 Hold
5
– – ﹤0.01% 1167
2023
Q2 		$1.09K Hold
5
– – ﹤0.01% 1147
2023
Q1 		$1.09K Hold
5
– – ﹤0.01% 1154
2022
Q4 		$1.04K Buy
+5
New +$1.1K ﹤0.01% 1156

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

North Star Investment Management's RMD Position: Q2 2026 in Review

North Star Investment Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 13 shares — an estimated $2.92K sold.

North Star Investment Management first reported a position in RMD in Q4 2022 and held it in 6 quarters. The position peaked at $2.92K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • North Star Investment Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • North Star Investment Management sold 13 ResMed shares in Q2 2026, an estimated $2.92K.
  • North Star Investment Management first reported a position in ResMed in Q4 2022 and held it in 6 quarters.
  • North Star Investment Management's ResMed position peaked at $2.92K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.